Physician profile
George Iskander
NPI 1457685034
$1,792.44
in general payments reported to CMS, 2019-2025
27 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $845 · 2021: $197 · 2022: $220 · 2023: $37.39 · 2024: $58.45 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $774.32 | 2020 | |
| Revance Therapeutics, INC. | $126.13 | 2025 | Daxxify |
| Aspira Women'S Health INC | $93.12 | 2021 | |
| Myovant Sciences INC. | $91.37 | 2021-2022 | |
| Hologic Sales and Service, LLC | $83.28 | 2019-2020 | |
| Pfizer INC. | $83.01 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $67.37 | 2025 | |
| Myriad Genetic Laboratories, INC. | $50.66 | 2022 | |
| Merck Sharp & Dohme LLC | $43.88 | 2021-2022 | |
| Boston Scientific Corporation | $36.22 | 2025 | Watchman Flx |
| Organogenesis INC. | $31.55 | 2024 | Puraply Am |
| Therapeuticsmd, INC. | $31.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.94 | 2019 | |
| Sumitomo Pharma America, INC. | $26.90 | 2024 | Myfembree |
| Meditrina | $24.97 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $24.86 | 2019 | |
| Teleflex LLC | $24.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.37 | 2021 | |
| Seagen INC. | $18.49 | 2022 | |
| Coopersurgical, INC. | $16.16 | 2023 | Endosee |
| Amag Pharmaceuticals, INC. | $15.95 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.46 | 2019 | |
| Smith+Nephew, INC. | $13.29 | 2022 | |
| Abbvie INC. | $13.29 | 2023 | |
| Allergan, INC. | $12.90 | 2019 | |
| Avion Pharmaceuticals | $10.96 | 2019 | |
| Intuitive Surgical, INC. | $7.94 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Iskander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.